Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

Condition:   HNSCC
Interventions:   Drug: Cetuximab;   Drug: avelumab;   Drug: Cisplatin;   Radiation: IMRT
Sponsors:   Groupe Oncologie Radiotherapie Tete et Cou;   Merck Sharp & Dohme Corp.;   Pfizer
Not yet recruiting - verified December 2016

http://ift.tt/2hTfzrQ